Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Cambrex Corporation    CBM   US1320111073

Delayed Quote. Delayed Nyse - 09/02 04:02:17 pm
22.07 USD   +0.68%
5d ago CAMBREX : to Exhibit at CPhI Worldwide 2014
08/07 CAMBREX : Sets Date for Second Quarter Results Conference Call
08/04 CAMBREX : Reports Second Quarter 2014 Financial Results
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/26/2014 08/27/2014 08/28/2014 08/29/2014 09/02/2014 Date
21.4(c) 21.42(c) 21.37(c) 21.92(c) 22.07 Last
365 445 273 290 109 659 275 047 370 985 Volume
-0.97% +0.09% -0.23% +2.57% +0.68% Change
More quotes
Company
Cambrex Corp. is a life sciences company. It provides products, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies its products and services worldwide to innovator and generic pharmaceutical companies. It products... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
More about the company
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 373 M
EBIT 2014 54,7 M
Net income 2014 34,7 M
Debt 2014 -
Yield 2014 -
Sales 2015 408 M
EBIT 2015 67,6 M
Net income 2015 43,9 M
Debt 2015 -
Yield 2015 -
PER 2014 19,93
PER 2015 15,66
Capi. / Sales 2014 1,80x
Capi. / Sales 2015 1,65x
Capitalization 673 M
More Financials
Latest news on CAMBREX CORPORATION
5d ago CAMBREX : to Exhibit at CPhI Worldwide 2014
08/07 CAMBREX : Sets Date for Second Quarter Results Conference Call
08/04 CAMBREX : Reports Second Quarter 2014 Financial Results
08/01 CAMBREX : Results of Operations and Financial Condition, Financial Statements an..
08/01 CAMBREX : Reports Second Quarter 2014 Financial Results
08/01 CAMBREX : Schedules Second Quarter Results Conference Call
07/29 CAMBREX : To Announce Second Quarter 2014 Financial Results On August 1, 2014
07/14 CAMBREX : Manufacturing Facility Completes Successful US FDA Pre-Approval Inspec..
07/12 CAMBREX : Manufacturing Facility Completes Successful US FDA Inspection
07/12 CAMBREX : Manufacturing Facility Completes Successful US FDA Pre-Approval Inspec..
07/09 CAMBREX : NeoStem Appoints Steven M. Klosk to Board of Directors
07/08 CAMBREX : NeoStem Appoints Steven M. Klosk to Board of Directors
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Cambrex Corporation : Income Statement Evolution
More Financials
EPS Revisions
Cambrex Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF